
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Cloudnine Hospitals has signed an agreement to acquire Apollo Cradle and Apollo Fertility. Consequently, this strategic combination will create one of India's largest integrated networks for maternity and fertility care. Under the deal, Apollo Health and Lifestyle Limited (AHLL) will merge its mother-and-child and fertility verticals with Cloudnine. This transaction, valued at ₹1,550 crore, marks a massive consolidation in women's healthcare.
This merger brings together two of the leading names in Indian specialized healthcare. Specifically, the combined platform will operate over 55 centres across major cities, including Bengaluru, Chennai, and Delhi NCR. Cloudnine currently operates 40 centres, while Apollo brings 12 maternity and 20 fertility units. Consequently, the consolidated group will provide unmatched healthcare access to diverse patient segments. Doctors and clinical staff will benefit from a highly integrated clinical governance framework. Furthermore, this massive clinical pool will enable better knowledge-sharing and standardized medical protocols.
From a financial standpoint, the deal values Apollo's standalone mother-and-child and fertility verticals at approximately ₹1,550 crore. A combination of cash consideration and equity will meet this valuation. As a result, AHLL will secure a 9.9% equity stake in the combined entity. This holding makes AHLL the largest non-financial shareholder in the platform. Additionally, Apollo will secure board representation through a nominee director. This strategic alignment ensures that both organizations actively contribute to future clinical expansions.
The specialized healthcare segment in India is witnessing rapid growth. Currently, analysts estimate India’s mother and childcare market at ₹30,000 crore. Moreover, experts project it to grow at a 15% compound annual rate over the next few years. Therefore, consolidated platforms hold a strategic position to meet this rising demand. Patients are increasingly seeking reliable, high-quality, and specialized clinical care. By leveraging their combined clinical expertise, these centers will continue to improve neonatal and maternal health outcomes nationwide.
Q1: What is the total valuation of the merger between Cloudnine and Apollo's verticals?
The transaction values Apollo Health and Lifestyle Limited's (AHLL) standalone mother-and-child and fertility verticals at approximately ₹1,550 crore, comprising cash and equity.
Q2: What will be Apollo's stake in the newly combined platform?
Apollo Health and Lifestyle Limited will hold a 9.9% equity stake in the combined entity, making it the largest non-financial shareholder with board representation.
Q3: How many centers will the combined entity operate across India?
The merged platform will operate more than 55 specialized centers across major Indian markets under a unified management structure.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Cloudnine acquires Apollo Cradle and Apollo Fertility in a ₹1,550 crore deal, creating India's largest integrated platform for maternity and fertility care....
4 days back

A large-scale study reveals a 25% higher risk of CKD in night shift workers, largely driven by obesity and disrupted fatty acid metabolism....
Today

The SRS 2024 report highlights a decline in India's infant mortality rate to 24, though severe state-level disparities and neonatal care gaps persist....
Today

A survey of 105 specialists identifies cost and procedural time as key barriers to IVUS use in CLTI revascularization, highlighting the need for randomized ...
Today

Researchers find that FLNB and TTC26 regulate ciliary Hedgehog signaling to maintain intervertebral disc matrix and prevent adolescent idiopathic scoliosis....
Today

Stanford scientists cured Type 1 diabetes in mice by transplanting stem and islet cells under a gentle, low-radiation protocol to reset the immune system....
Today